Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-I Weng
Epigenetic Silencing Mediated Through Activated PI3K/AKT Signaling in Breast Cancer
Cancer Research
Cancer Research
Oncology
Related publications
Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
Cancer Research
Cancer Research
Oncology
FOXC1 Silencing Promotes A549 Cell Apoptosis Through Inhibiting the PI3K/AKT/hedgehog/Gli2 Signaling Pathway
RSC Advances
Chemistry
Chemical Engineering
FOXP1 Regulation via the PI3K/Akt/p70S6K Signaling Pathway in Breast Cancer Cells
Oncology Letters
Cancer Research
Oncology
CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
Cancer Management and Research
Oncology
Resveratrol Attenuates Oxidative Stress-Induced Intestinal Barrier Injury Through PI3K/Akt-Mediated Nrf2 Signaling Pathway
Oxidative Medicine and Cellular Longevity
Biochemistry
Medicine
Cell Biology
Aging
miR-19b Serves as a Prognostic Biomarker of Breast Cancer and Promotes Tumor Progression Through PI3K/AKT Signaling Pathway
OncoTargets and Therapy
Oncology
Pharmacology
PIAS1 Regulates Breast Tumorigenesis Through Selective Epigenetic Gene Silencing
PLoS ONE
Multidisciplinary
Activation of Autophagy During Farnesyl Pyrophosphate Synthase Inhibition Is Mediated Through PI3K/AKT/mTOR Signaling
Journal of International Medical Research
Biochemistry
Medicine
Cell Biology
Pristimerin Overcomes Adriamycin Resistance in Breast Cancer Cells Through Suppressing Akt Signaling
Oncology Letters
Cancer Research
Oncology